Shareholders did not give UK hospital group Spire’s full year results a warm reception, despite a return to profit, generally strong financials, and the continued viability of the UK market. HBI talks to market experts to find out why.
Archives
Ramsay bounces back from sale saga with strong H1 results
The half-year results of Australia-based multinational hospital group Ramsay Health Care were received positively by investors as revenue, profit and EBITDA all saw a jump.
March 3, 2023
Government pressure could see mass resignations of Hungarian doctors
The Hungarian government has demonised the Hungarian Medical Chamber (MOK) after the doctor's union warned its members not to sign up to an on-call system for GPs. It sparks fresh concerns of a workforce exodus at a time when patients are increasingly turn to private care - and could be a boon for for-profits.
March 3, 2023
HBI Deals+Insights briefing March 2023: Deals + Insights members
Click here to download your Deals+Insights March 2023 Shareholders heard about “Future Fresenius” this month and as the multinational group set out its plans, we asked why shareholders appeared unconvinced. A trip to Arab Health put Saudi Arabia and its billion-dollar opportunities firmly in the spotlight, while French nursing home group DomusVi found itself robustly […]
February 25, 2023
Shareholders unconvinced by “future Fresenius”
Michael Sen, CEO of multinational healthcare conglomerate Fresenius, finally set out his long-awaited plan for a “Future Fresenius” at the group’s end of year results this week. But is it a radical shake up, or PR puff? HBI investigates why shareholders appear unconvinced.
February 24, 2023
Employers driving up Scandi PMI
Despite its reputation for excellent public healthcare and an economy as close to socialist as a capitalist country can be, private medical insurance (PMI) is on the up in Scandinavia. HBI speaks to three operators to find out more.
February 24, 2023
Legal challenges may derail German investor crackdown
HBI hears German health minister Karl Lauterbach’s plan to stop “locust investors” from buying up outpatient facilities may be shot down by a double whammy of legal and political considerations. HBI speaks to a Germany-based lawyer and healthcare expert to find out more.
February 24, 2023
Danish outsourcing deal ‘has broad consensus’
Last week we reported that some operators had expressed concerns after the Danish government made a new outsourcing agreement with the private hospital sector. This week we hear from operators more supportive of the development, who are keen to share a different perspective.
February 24, 2023
Fresenius to deconsolidate FMC
Michael Sen, the new CEO of multinational health care conglomerate Fresenius, is making preparations to deconsolidate struggling dialysis subsidiary Fresenius Medical Care (FMC). The plans fall short of full divestment and may not be radical enough to appease investors.
February 10, 2023
TFP up for sale
HBI hears UK-based pan-European fertility group TFP is up for sale, and speaks to two well-placed sources to find out more.
February 10, 2023
Linde healthcare sales growth down despite great results
Global chemicals company Linde reported a 1% year-on-year drop in sales growth for healthcare, despite double-digit sales growth in all its other end markets.
February 9, 2023
Norwegian hospitals struggle in the face of government outsourcing hostility
The Norwegian private hospital market is stagnating because of government unwillingness to outsource care to the private sector – despite growing waiting lists for public patients.
